TESAMORELIN (10 MG)

 Tesamorelin is the peptide researchers reach for when they want to study targeted visceral fat reduction without wrecking lean mass. It’s been clinically evaluated for abdominal fat in specific populations and remains a powerful tool for understanding how GH and IGF-1 modulation affects body composition and metabolic markers.

How It Works
Tesamorelin is a GHRH analog that binds GHRH receptors in the anterior pituitary, triggering a more physiologic, pulsatile release of growth hormone. Increased GH leads to enhanced lipolysis, especially in visceral adipose tissue, and upregulation of IGF-1, which supports protein synthesis and lean tissue. This GH/IGF-1 axis is central to how researchers model changes in fat distribution and metabolic health.

Regulatory & Research Note
Tesamorelin is FDA-approved for treatment of HIV-associated lipodystrophy. Any other indication, dosing, or usage is off-label or investigational. This product is supplied for research use only and is not for human consumption or therapeutic use.